Rheumnow

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.

Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me (jackcush@rheumnow.com) or recording your suggestion using the "Ask Cush Anything" link on our email and website.

Dr. Jack Cush reviews the news, journal reports, ACR and FDA announcements from the past week on RheumNow.com

Can we predict the bad outcomes? Like when ITP evolves into SLE; or when psoriasis will develop arthritis; or if  Sjogens will develop lymphoma?  Dr. Jack Cush reviews these journal reports and this past weeks news from RheumNow.com

Featuring a discussion with Dr. Susan Shenoi from Seattle Childrens Hospital

Dr. Jack Cush discusses declining survival rates in the USA, FDA approvals of new COVID subvariant boosters and other odd and possibly true new research reports from the past week on RheumNow.com.

Rainbow Rheumatology (8.26.2022) Dr. Jack Cush delivers this weeks rheumatology "weather report" with the best and least of news and journal articles from the past week on RheumNow.com “Climate is what we expect, weather is what we get.” – Mark Twain

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow and discusses a case of refractory juvenile dermatomyositis with calcinosis.

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. This week the run down is based on popularity, measured by rheumatologist engagements on the website and social media.

Dr. Jack Cush reviews the news, FDA approvals, journal articles from the past week on RheumNow; plus viewer questions. This week great hopes for vitamin D, the great unknows of CSA and the great big mess that is the gout.

Drs. Jack Cush and Rachel Tate discuss the launch of the updated StillsNow.com website and the new monthly podcast from StillsNow.com. This podcast ends with a Still's disease quiz for rheumatologists.

QD197 - Still's (or Not) NEJM CPC  https://youtu.be/_xnCaxeqidw QD198 - Still's (or Not) with Daily Fevers   https://youtu.be/J1bezuA-f_s QD199 - Still's (or Not): an FUO Evaluation   https://youtu.be/0qDijCAqEpQ QD200 - Still's (or Not): Fever, Joint pain & Itchy Eyes  https://youtu.be/utvFA1lx1lc

Dr. Jack Cush reviews the news, journal reports and rheumatologist cases from the past week on RheumNow.com. This podcast is brought to you by StillsNow.com - be sure to sign up for our monthly StillsNow email and Monthly StillsNow Podcast.

This week's Stills disease Journal Club features expert discussants Drs. Olga Petryna, Daniel Lovell, Hermine Brunner and Jack Cush. Journal articles reviewed includes:  - CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease. Kedor C. Ann Rheum Dis 2020 Aug;79:1090-1097  https://bit.ly/3coPFg0 - TENDER Trial. Tocilizumab in systemic juvenile idiopathic arthritis. De Benedetti F. N Engl J Med. 2012 Dec 20;367:2385-95 https://bit.ly/3uXFq8Q

Join Dr. Michael Weisman, Dr. Bella Mehta and Dr. Jack Cush in this live, one-hour Journal Club to discuss: 1. Still's disease in the adult. EGL Bywaters. Annals of Rheumatic Disease 1971 2. Juvenile rheumatoid arthritis presenting in the adult as fever of unknown origin. J Bujak, et al. Medicine 1973

Dr. Jack Cush reviews the new studies and drug approvals and new insights into febrile disorders from the past week on RheumNow.com

QD193 - Stills (or Not) MAS off of Tocilizumab   https://youtu.be/xIco2Xdxf68 QD194 - Stills (or Not) with Widespread Pain   https://youtu.be/50BXYafkVZM QD 195 - Stills (or Not) with Hives    https://youtu.be/f4tPMylrnpQ QD 196 - Stills (or Not); A Wifes Letter   https://youtu.be/eRnisH0Hjhw

Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021. My Top 10 list 1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod  2. New FDA Indications 3.  New Biologics for Lupus 4. Super "H" Hydroxychloroquine 5. Zoomatology 6. Avacopan 7. Tocilizumab 8. FDA & JAK inhibitor warnings 9. New Biologics for GCA 10. IL-23 Inhibitors https://rheumnow.com/news/2021-rheumatology-year-review-172022

Still's disease is the most common rheumatic cause of unknown fever in adults. This series by Dr. Jack Cush covers the definition, history, epidemiology, key manifestations and labs, diagnostic criteria, pathogenesis and the management of adult-onset Still's disease.  Dr. Cush is the executive editor of StillsNow.com - a new medical education site focused on Still's disease and other febrile autoinflammatory disorders. You can subscribe to the website's monthly email with updated social media, news articles, videos and podcasts for physicians, patients and healthcare providers caring for patients with febrile disorders.